Medical Care

Human Microbiome - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us, in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
The global market for Human Microbiome was estimated to be worth US$ 384.9 million in 2023 and is forecast to a readjusted size of US$ 1544.9 million by 2030 with a CAGR of 21.7% during the forecast period 2024-2030
At present, global investment concentrates in US and Europe, US takes 70% market share and Europe takes 25% market share. There are a few manufacturers in the world and the market concentration is high. The top5 (investment in Human Micobiome) companies are Vedanta, Seres Therapeutics, Second Genome, Rebiocix, ActoGeniX. The five companies occupy about 70% of the market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Microbiome, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Human Microbiome by region & country, by Type, and by Application.
The Human Microbiome market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Microbiome.
Market Segmentation
By Company
Vedanta
Seres Therapeutics
Second Genome
Rebiotix
ActoGeniX
Enterome BioScience
AvidBiotics
4D Pharma Research Ltd
Enterologics
Metabogen
Metabiomics
Ritter Pharmaceuticals
Osel
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC
Segment by Type:
Gastrointestinal Tract Human Micobiome
Urogenital Tract Human Micobiome
Others
Segment by Application
Treatment
Diagnosis
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Human Microbiome manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Human Microbiome in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Human Microbiome in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Human Microbiome Product Introduction
1.2 Global Human Microbiome Market Size Forecast
1.3 Human Microbiome Market Trends & Drivers
1.3.1 Human Microbiome Industry Trends
1.3.2 Human Microbiome Market Drivers & Opportunity
1.3.3 Human Microbiome Market Challenges
1.3.4 Human Microbiome Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Human Microbiome Players Revenue Ranking (2023)
2.2 Global Human Microbiome Revenue by Company (2019-2024)
2.3 Key Companies Human Microbiome Manufacturing Base Distribution and Headquarters
2.4 Key Companies Human Microbiome Product Offered
2.5 Key Companies Time to Begin Mass Production of Human Microbiome
2.6 Human Microbiome Market Competitive Analysis
2.6.1 Human Microbiome Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Human Microbiome Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Gastrointestinal Tract Human Micobiome
3.1.2 Urogenital Tract Human Micobiome
3.1.3 Others
3.2 Global Human Microbiome Sales Value by Type
3.2.1 Global Human Microbiome Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Human Microbiome Sales Value, by Type (2019-2030)
3.2.3 Global Human Microbiome Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Treatment
4.1.2 Diagnosis
4.2 Global Human Microbiome Sales Value by Application
4.2.1 Global Human Microbiome Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Human Microbiome Sales Value, by Application (2019-2030)
4.2.3 Global Human Microbiome Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Human Microbiome Sales Value by Region
5.1.1 Global Human Microbiome Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Human Microbiome Sales Value by Region (2019-2024)
5.1.3 Global Human Microbiome Sales Value by Region (2025-2030)
5.1.4 Global Human Microbiome Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Human Microbiome Sales Value, 2019-2030
5.2.2 North America Human Microbiome Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Human Microbiome Sales Value, 2019-2030
5.3.2 Europe Human Microbiome Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Human Microbiome Sales Value, 2019-2030
5.4.2 Asia Pacific Human Microbiome Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Human Microbiome Sales Value, 2019-2030
5.5.2 South America Human Microbiome Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Human Microbiome Sales Value, 2019-2030
5.6.2 Middle East & Africa Human Microbiome Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Human Microbiome Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Human Microbiome Sales Value
6.3 United States
6.3.1 United States Human Microbiome Sales Value, 2019-2030
6.3.2 United States Human Microbiome Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Human Microbiome Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Human Microbiome Sales Value, 2019-2030
6.4.2 Europe Human Microbiome Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Human Microbiome Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Human Microbiome Sales Value, 2019-2030
6.5.2 China Human Microbiome Sales Value by Type (%), 2023 VS 2030
6.5.3 China Human Microbiome Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Human Microbiome Sales Value, 2019-2030
6.6.2 Japan Human Microbiome Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Human Microbiome Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Human Microbiome Sales Value, 2019-2030
6.7.2 South Korea Human Microbiome Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Human Microbiome Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Human Microbiome Sales Value, 2019-2030
6.8.2 Southeast Asia Human Microbiome Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Human Microbiome Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Human Microbiome Sales Value, 2019-2030
6.9.2 India Human Microbiome Sales Value by Type (%), 2023 VS 2030
6.9.3 India Human Microbiome Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Vedanta
7.1.1 Vedanta Profile
7.1.2 Vedanta Main Business
7.1.3 Vedanta Human Microbiome Products, Services and Solutions
7.1.4 Vedanta Human Microbiome Revenue (US$ Million) & (2019-2024)
7.1.5 Vedanta Recent Developments
7.2 Seres Therapeutics
7.2.1 Seres Therapeutics Profile
7.2.2 Seres Therapeutics Main Business
7.2.3 Seres Therapeutics Human Microbiome Products, Services and Solutions
7.2.4 Seres Therapeutics Human Microbiome Revenue (US$ Million) & (2019-2024)
7.2.5 Seres Therapeutics Recent Developments
7.3 Second Genome
7.3.1 Second Genome Profile
7.3.2 Second Genome Main Business
7.3.3 Second Genome Human Microbiome Products, Services and Solutions
7.3.4 Second Genome Human Microbiome Revenue (US$ Million) & (2019-2024)
7.3.5 Rebiotix Recent Developments
7.4 Rebiotix
7.4.1 Rebiotix Profile
7.4.2 Rebiotix Main Business
7.4.3 Rebiotix Human Microbiome Products, Services and Solutions
7.4.4 Rebiotix Human Microbiome Revenue (US$ Million) & (2019-2024)
7.4.5 Rebiotix Recent Developments
7.5 ActoGeniX
7.5.1 ActoGeniX Profile
7.5.2 ActoGeniX Main Business
7.5.3 ActoGeniX Human Microbiome Products, Services and Solutions
7.5.4 ActoGeniX Human Microbiome Revenue (US$ Million) & (2019-2024)
7.5.5 ActoGeniX Recent Developments
7.6 Enterome BioScience
7.6.1 Enterome BioScience Profile
7.6.2 Enterome BioScience Main Business
7.6.3 Enterome BioScience Human Microbiome Products, Services and Solutions
7.6.4 Enterome BioScience Human Microbiome Revenue (US$ Million) & (2019-2024)
7.6.5 Enterome BioScience Recent Developments
7.7 AvidBiotics
7.7.1 AvidBiotics Profile
7.7.2 AvidBiotics Main Business
7.7.3 AvidBiotics Human Microbiome Products, Services and Solutions
7.7.4 AvidBiotics Human Microbiome Revenue (US$ Million) & (2019-2024)
7.7.5 AvidBiotics Recent Developments
7.8 4D Pharma Research Ltd
7.8.1 4D Pharma Research Ltd Profile
7.8.2 4D Pharma Research Ltd Main Business
7.8.3 4D Pharma Research Ltd Human Microbiome Products, Services and Solutions
7.8.4 4D Pharma Research Ltd Human Microbiome Revenue (US$ Million) & (2019-2024)
7.8.5 4D Pharma Research Ltd Recent Developments
7.9 Enterologics
7.9.1 Enterologics Profile
7.9.2 Enterologics Main Business
7.9.3 Enterologics Human Microbiome Products, Services and Solutions
7.9.4 Enterologics Human Microbiome Revenue (US$ Million) & (2019-2024)
7.9.5 Enterologics Recent Developments
7.10 Metabogen
7.10.1 Metabogen Profile
7.10.2 Metabogen Main Business
7.10.3 Metabogen Human Microbiome Products, Services and Solutions
7.10.4 Metabogen Human Microbiome Revenue (US$ Million) & (2019-2024)
7.10.5 Metabogen Recent Developments
7.11 Metabiomics
7.11.1 Metabiomics Profile
7.11.2 Metabiomics Main Business
7.11.3 Metabiomics Human Microbiome Products, Services and Solutions
7.11.4 Metabiomics Human Microbiome Revenue (US$ Million) & (2019-2024)
7.11.5 Metabiomics Recent Developments
7.12 Ritter Pharmaceuticals
7.12.1 Ritter Pharmaceuticals Profile
7.12.2 Ritter Pharmaceuticals Main Business
7.12.3 Ritter Pharmaceuticals Human Microbiome Products, Services and Solutions
7.12.4 Ritter Pharmaceuticals Human Microbiome Revenue (US$ Million) & (2019-2024)
7.12.5 Ritter Pharmaceuticals Recent Developments
7.13 Osel
7.13.1 Osel Profile
7.13.2 Osel Main Business
7.13.3 Osel Human Microbiome Products, Services and Solutions
7.13.4 Osel Human Microbiome Revenue (US$ Million) & (2019-2024)
7.13.5 Osel Recent Developments
7.14 Symberix
7.14.1 Symberix Profile
7.14.2 Symberix Main Business
7.14.3 Symberix Human Microbiome Products, Services and Solutions
7.14.4 Symberix Human Microbiome Revenue (US$ Million) & (2019-2024)
7.14.5 Symberix Recent Developments
7.15 Miomics
7.15.1 Miomics Profile
7.15.2 Miomics Main Business
7.15.3 Miomics Human Microbiome Products, Services and Solutions
7.15.4 Miomics Human Microbiome Revenue (US$ Million) & (2019-2024)
7.15.5 Miomics Recent Developments
7.16 Symbiotix Biotherapies
7.16.1 Symbiotix Biotherapies Profile
7.16.2 Symbiotix Biotherapies Main Business
7.16.3 Symbiotix Biotherapies Human Microbiome Products, Services and Solutions
7.16.4 Symbiotix Biotherapies Human Microbiome Revenue (US$ Million) & (2019-2024)
7.16.5 Symbiotix Biotherapies Recent Developments
7.17 MicroBiome Therapeutics LLC
7.17.1 MicroBiome Therapeutics LLC Profile
7.17.2 MicroBiome Therapeutics LLC Main Business
7.17.3 MicroBiome Therapeutics LLC Human Microbiome Products, Services and Solutions
7.17.4 MicroBiome Therapeutics LLC Human Microbiome Revenue (US$ Million) & (2019-2024)
7.17.5 MicroBiome Therapeutics LLC Recent Developments
8 Industry Chain Analysis
8.1 Human Microbiome Industrial Chain
8.2 Human Microbiome Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Human Microbiome Sales Model
8.5.2 Sales Channel
8.5.3 Human Microbiome Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Human Microbiome Market Trends
Table 2. Human Microbiome Market Drivers & Opportunity
Table 3. Human Microbiome Market Challenges
Table 4. Human Microbiome Market Restraints
Table 5. Global Human Microbiome Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Human Microbiome Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Human Microbiome Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Human Microbiome Product Type
Table 9. Key Companies Time to Begin Mass Production of Human Microbiome
Table 10. Global Human Microbiome Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Human Microbiome Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Human Microbiome Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Human Microbiome Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Human Microbiome Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Human Microbiome Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Human Microbiome Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Human Microbiome Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Human Microbiome Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Human Microbiome Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Human Microbiome Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Human Microbiome Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Human Microbiome Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Human Microbiome Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Human Microbiome Sales Value by Region (2019-2024) & (%)
Table 27. Global Human Microbiome Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Human Microbiome Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Human Microbiome Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Human Microbiome Sales Value, (2025-2030) & (US$ Million)
Table 31. Vedanta Basic Information List
Table 32. Vedanta Description and Business Overview
Table 33. Vedanta Human Microbiome Products, Services and Solutions
Table 34. Revenue (US$ Million) in Human Microbiome Business of Vedanta (2019-2024)
Table 35. Vedanta Recent Developments
Table 36. Seres Therapeutics Basic Information List
Table 37. Seres Therapeutics Description and Business Overview
Table 38. Seres Therapeutics Human Microbiome Products, Services and Solutions
Table 39. Revenue (US$ Million) in Human Microbiome Business of Seres Therapeutics (2019-2024)
Table 40. Seres Therapeutics Recent Developments
Table 41. Second Genome Basic Information List
Table 42. Second Genome Description and Business Overview
Table 43. Second Genome Human Microbiome Products, Services and Solutions
Table 44. Revenue (US$ Million) in Human Microbiome Business of Second Genome (2019-2024)
Table 45. Second Genome Recent Developments
Table 46. Rebiotix Basic Information List
Table 47. Rebiotix Description and Business Overview
Table 48. Rebiotix Human Microbiome Products, Services and Solutions
Table 49. Revenue (US$ Million) in Human Microbiome Business of Rebiotix (2019-2024)
Table 50. Rebiotix Recent Developments
Table 51. ActoGeniX Basic Information List
Table 52. ActoGeniX Description and Business Overview
Table 53. ActoGeniX Human Microbiome Products, Services and Solutions
Table 54. Revenue (US$ Million) in Human Microbiome Business of ActoGeniX (2019-2024)
Table 55. ActoGeniX Recent Developments
Table 56. Enterome BioScience Basic Information List
Table 57. Enterome BioScience Description and Business Overview
Table 58. Enterome BioScience Human Microbiome Products, Services and Solutions
Table 59. Revenue (US$ Million) in Human Microbiome Business of Enterome BioScience (2019-2024)
Table 60. Enterome BioScience Recent Developments
Table 61. AvidBiotics Basic Information List
Table 62. AvidBiotics Description and Business Overview
Table 63. AvidBiotics Human Microbiome Products, Services and Solutions
Table 64. Revenue (US$ Million) in Human Microbiome Business of AvidBiotics (2019-2024)
Table 65. AvidBiotics Recent Developments
Table 66. 4D Pharma Research Ltd Basic Information List
Table 67. 4D Pharma Research Ltd Description and Business Overview
Table 68. 4D Pharma Research Ltd Human Microbiome Products, Services and Solutions
Table 69. Revenue (US$ Million) in Human Microbiome Business of 4D Pharma Research Ltd (2019-2024)
Table 70. 4D Pharma Research Ltd Recent Developments
Table 71. Enterologics Basic Information List
Table 72. Enterologics Description and Business Overview
Table 73. Enterologics Human Microbiome Products, Services and Solutions
Table 74. Revenue (US$ Million) in Human Microbiome Business of Enterologics (2019-2024)
Table 75. Enterologics Recent Developments
Table 76. Metabogen Basic Information List
Table 77. Metabogen Description and Business Overview
Table 78. Metabogen Human Microbiome Products, Services and Solutions
Table 79. Revenue (US$ Million) in Human Microbiome Business of Metabogen (2019-2024)
Table 80. Metabogen Recent Developments
Table 81. Metabiomics Basic Information List
Table 82. Metabiomics Description and Business Overview
Table 83. Metabiomics Human Microbiome Products, Services and Solutions
Table 84. Revenue (US$ Million) in Human Microbiome Business of Metabiomics (2019-2024)
Table 85. Metabiomics Recent Developments
Table 86. Ritter Pharmaceuticals Basic Information List
Table 87. Ritter Pharmaceuticals Description and Business Overview
Table 88. Ritter Pharmaceuticals Human Microbiome Products, Services and Solutions
Table 89. Revenue (US$ Million) in Human Microbiome Business of Ritter Pharmaceuticals (2019-2024)
Table 90. Ritter Pharmaceuticals Recent Developments
Table 91. Osel Basic Information List
Table 92. Osel Description and Business Overview
Table 93. Osel Human Microbiome Products, Services and Solutions
Table 94. Revenue (US$ Million) in Human Microbiome Business of Osel (2019-2024)
Table 95. Osel Recent Developments
Table 96. Symberix Basic Information List
Table 97. Symberix Description and Business Overview
Table 98. Symberix Human Microbiome Products, Services and Solutions
Table 99. Revenue (US$ Million) in Human Microbiome Business of Symberix (2019-2024)
Table 100. Symberix Recent Developments
Table 101. Miomics Basic Information List
Table 102. Miomics Description and Business Overview
Table 103. Miomics Human Microbiome Products, Services and Solutions
Table 104. Revenue (US$ Million) in Human Microbiome Business of Miomics (2019-2024)
Table 105. Miomics Recent Developments
Table 106. Symbiotix Biotherapies Basic Information List
Table 107. Symbiotix Biotherapies Description and Business Overview
Table 108. Symbiotix Biotherapies Human Microbiome Products, Services and Solutions
Table 109. Revenue (US$ Million) in Human Microbiome Business of Symbiotix Biotherapies (2019-2024)
Table 110. Symbiotix Biotherapies Recent Developments
Table 111. MicroBiome Therapeutics LLC Basic Information List
Table 112. MicroBiome Therapeutics LLC Description and Business Overview
Table 113. MicroBiome Therapeutics LLC Human Microbiome Products, Services and Solutions
Table 114. Revenue (US$ Million) in Human Microbiome Business of MicroBiome Therapeutics LLC (2019-2024)
Table 115. MicroBiome Therapeutics LLC Recent Developments
Table 116. Key Raw Materials Lists
Table 117. Raw Materials Key Suppliers Lists
Table 118. Human Microbiome Downstream Customers
Table 119. Human Microbiome Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 123. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Human Microbiome Product Picture
Figure 2. Global Human Microbiome Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Human Microbiome Sales Value (2019-2030) & (US$ Million)
Figure 4. Human Microbiome Report Years Considered
Figure 5. Global Human Microbiome Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Microbiome Revenue in 2023
Figure 7. Human Microbiome Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Gastrointestinal Tract Human Micobiome Picture
Figure 9. Urogenital Tract Human Micobiome Picture
Figure 10. Others Picture
Figure 11. Global Human Microbiome Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Human Microbiome Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Treatment
Figure 14. Product Picture of Diagnosis
Figure 15. Global Human Microbiome Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Human Microbiome Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Human Microbiome Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Human Microbiome Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Human Microbiome Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Human Microbiome Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Human Microbiome Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Human Microbiome Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Human Microbiome Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Human Microbiome Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Human Microbiome Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Human Microbiome Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Human Microbiome Sales Value (%), (2019-2030)
Figure 28. United States Human Microbiome Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Human Microbiome Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Human Microbiome Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Human Microbiome Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Human Microbiome Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Human Microbiome Sales Value by Application (%), 2023 VS 2030
Figure 34. China Human Microbiome Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Human Microbiome Sales Value by Type (%), 2023 VS 2030
Figure 36. China Human Microbiome Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Human Microbiome Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Human Microbiome Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Human Microbiome Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Human Microbiome Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Human Microbiome Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Human Microbiome Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Human Microbiome Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Human Microbiome Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Human Microbiome Sales Value by Application (%), 2023 VS 2030
Figure 46. India Human Microbiome Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Human Microbiome Sales Value by Type (%), 2023 VS 2030
Figure 48. India Human Microbiome Sales Value by Application (%), 2023 VS 2030
Figure 49. Human Microbiome Industrial Chain
Figure 50. Human Microbiome Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies